Annals of Oncology, 1569-8041

Journal

More filtering options
  1. 2008
  2. Sox11, a non-B cell lineage transcription factor, is overexpressed in mantle cell lymphoma

    Michael Dictor, Sara Ek, Mats Jerkeman, Karin Jirström & Carl Borrebaeck, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 172-iv 173

    Research output: Contribution to journalPublished meeting abstract

  3. Transformed diffuse large B cell lymphomas differ from follicular lymphomas in both gene and protein expression

    Ulrika Andreasson, Michael Dictor, Mats Jerkeman, Rosenquist, R., Carl Borrebaeck & Sara Ek, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 111-iv 111

    Research output: Contribution to journalPublished meeting abstract

  4. 2007
  5. Familial blood vessel tumors and subsequent cancers

    J. Ji & K. Hemminki, 2007 Jul 1, In : Annals of Oncology. 18, 7, p. 1260-1267 8 p.

    Research output: Contribution to journalArticle

  6. Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up

    Bjoerkholm, M., Hagberg, H., Holte, H., Kvaloy, S., Teerenhovi, L., Anderson, H., Cavallin-Ståhl, E., Myhre, J., Pertovaara, H., Oest, A., Nilsson, B. & Oesby, E., 2007, In : Annals of Oncology. 18, 6, p. 1085-1089

    Research output: Contribution to journalArticle

  7. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers

    Vineis, P., Veglia, F., Garte, S., Malaveille, C., Matullo, G., Dunning, A., Peluso, M., Airoldi, L., Overvad, K., Raaschou-Nielsen, O., Clavel-Chapelon, F., Linseisen, J. P., Kaaks, R., Boeing, H., Trichopoulou, A., Palli, D., Crosignani, P., Tumino, R., Panico, S., Bueno-De-Mesquita, H. B. & 15 others, Peeters, P. H., Lund, E., Gonzalez, C. A., Martinez, C., Dorronsor, M., Barricarte, A., Navarro, C., Quiros, J. R., Berglund, G., Jarvholm, B., Day, N. E., Key, T. J., Saracci, R., Riboli, E. & Autrup, H., 2007, In : Annals of Oncology. 18, 7, p. 1230-1242

    Research output: Contribution to journalArticle

  8. Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy

    Wilking, N., Lidbrink, E., Wiklund, T., Erikstein, B., Lindman, H., Per Malmström, Kellokumpu-Lehtinen, P., Bengtsson, N. -O., Soederlund, G., Anker, G., Wist, E., Ottosson, S., Salminen, E., Ljungman, P., Holte, H., Nilsson, J., Blomqvist, C. & Bergh, J., 2007, In : Annals of Oncology. 18, 4, p. 694-700

    Research output: Contribution to journalArticle

  9. Targeted therapy in nuclear medicine current status and future prospects

    Oyen, W. J. G., Bodei, L., Giammarile, F., Maecke, H. R., Jan Tennvall, Luster, M. & Brans, B., 2007, In : Annals of Oncology. 18, 11, p. 1782-1792

    Research output: Contribution to journalArticle

  10. 2006
  11. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

    Barkholt, L., Bregni, M., Remberger, M., Blaise, D., Peccatori, J., Massenkeil, G., Pedrazzoli, P., Zambelli, A., Bay, J. -O., Francois, S., Martino, R., Bengala, C., Brune, M., Lenhoff, S., Porcellini, A., Falda, M., Siena, S., Demirer, T., Niederwieser, D. & Ringden, O., 2006, In : Annals of Oncology. 17, 7, p. 1134-1140

    Research output: Contribution to journalArticle

  12. 2005
  13. 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration

    Stuart, G., Avall-Lundqvist, E., du Bois, A., Bookman, M., Bowtell, D., Brady, M., Casado, A., Cervantes, A., Eisenhauer, E., Friedlaender, M., Fujiwara, K., Grenman, S., Guastalla, J. P., Harper, P., Hogberg, T., Kaye, S., Kitchener, H., Kristensen, G., Mannel, R., Meier, W. & 21 others, Miller, B., Oza, A., Ozols, R., Parmar, M., Pfisterer, J., Poveda, A., Provencher, D., Pujade-Lauraine, E., Quinn, M., Randall, M., Rochon, J., Rustin, G., Sagae, S., Stehman, F., Trimble, E., Thigpen, T., Vasey, P., Vergote, I., Verheijen, R., Vermorken, J. & Wagner, U., 2005, In : Annals of oncology : official journal of the European Society for Medical Oncology. 16, Suppl 8, p. viii36-viii38

    Research output: Contribution to journalArticle

  14. Clinical trials in ovarian carcinoma: study methodology

    Vermorken, J. B., Parmar, M. K. B., Brady, M. F., Eisenhauer, E. A., T Hogberg, Ozols, R. F., Rochon, J., Rustin, G. J. S., Sagae, S. & Verheijen, R. H. M., 2005, In : Annals of oncology : official journal of the European Society for Medical Oncology. 16 , Suppl 8, p. viii20-viii29

    Research output: Contribution to journalArticle

  15. 2004
  16. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma

    Ferreri, AJM., Campo, E., Arnbrosetti, A., Ilariucci, F., Seymour, JF., Willemze, R., Arrigoni, G., Rossi, G., Lopez-Guillermo, A., Berti, E., Eriksson, M., Federico, M., Cortelazzo, S., Govi, S., Frungillo, N., Dell'Oro, S., Lestani, M., Asioli, S., Pedrinis, E., Ungari, M. & 7 others, Motta, T., Rossi, R., Artusi, T., Iuzzolino, P., Zucca, E., Cavalli, F. & Ponzoni, M., 2004, In : Annals of Oncology. 15, 8, p. 1215-1221

    Research output: Contribution to journalArticle

  17. Colon cancer prevalence and estimation of differing care needs of colon cancer patients

    Gatta, G., Capocaccia, R., Berrino, F., Ruzza, M. R., Contiero, P., Möller, T. & EUROPREVAL Working Group, A. T., 2004, In : Annals of Oncology. 15, 7, p. 1136-1142

    Research output: Contribution to journalArticle

  18. External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years

    Mueller, CR., Ulf Kristoffersson & Stoppa-Lyonnet, D., 2004, In : Annals of Oncology. 15, Suppl. 1, p. I14-I17

    Research output: Contribution to journalArticle

  19. 2003
  20. Cancer prevalence in Northern Europe: the EUROPREVAL study.

    Möller, T., Anderson, H., Aareleid, T., Hakulinen, T., Storm, H., Tryggvadottir, L., Corazziari, I. & Mugno, E., 2003, In : Annals of Oncology. 14, 6, p. 946-957

    Research output: Contribution to journalArticle

  21. 2002
  22. Cancer prevalence in European registry areas

    Micheli, A., Mugno, E., Krogh, V., Quinn, M. J., Coleman, M., Hakulinen, T., Gatta, G., Berrino, F., Capocaccia, R., EUROPREVAL Working Group:, T., Möller, T., Anderson, H. & al, E., 2002, In : Annals of Oncology. 13, 6, p. 840-865

    Research output: Contribution to journalArticle

  23. Measuring cancer prevalence in Europe: the EUROPREVAL project

    Capocaccia, R., Colonna, M., Corazziari, I., De Angelis, R., Francisci, S., Micheli, A., Mugno, E., EUROPREVAL Working Group:, T., Möller, T., Anderson, H. & al, E., 2002, In : Annals of Oncology. 13, 6, p. 831-839

    Research output: Contribution to journalArticle

  24. 2001
  25. Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation

    Picci, P., Vanel, D., Briccoli, A., Talle, K., Haakenaasen, U., Malaguti, C., Monti, C., Ferrari, C., Bacci, G., Saeter, G. & Thor Alvegård, 2001, In : Annals of Oncology. 12, 11, p. 1601-1604

    Research output: Contribution to journalArticle

  26. Neuroendocrine pathogenesis in adenocarcinoma of the prostate

    Jens Ceder & Abrahamsson, P-A., 2001, In : Annals of Oncology. 12, Suppl. 2, p. S145-S152

    Research output: Contribution to journalArticle

  27. 2000
  28. Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument

    Tropé, C., Kaern, J., T Hogberg, Abeler, V., Hagen, B., Kristensen, G., Onsrud, M., Pettersen, E., Rosenberg, P., Sandvei, R., Sundfor, K. & Vergote, I., 2000 Mar, In : Annals of oncology : official journal of the European Society for Medical Oncology. 11, 3, p. 281-8 8 p.

    Research output: Contribution to journalArticle

  29. 1999
  30. CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial

    Mats Jerkeman, Anderson, H., Cavallin-Ståhl, E., Michael Dictor, Hagberg, H., Johnson, A., Kaasa, S., Kvaloy, S., Sundstrom, C. & Åkerman, M., 1999, In : Annals of Oncology. 10, 9, p. 1079-1086

    Research output: Contribution to journalArticle

  31. 1998
  32. Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experience

    Tropé, C., Hogberg, T., Kaern, J., Bertelsen, K., Bjorkholm, E., Boman, K., Himmelmann, A., Horvath, G., Jacobsen, A., Kuoppola, T., Vartianen, J., Lund, B., Onsrud, M., Puistola, U., Salmi, T., Scheistroen, M., Sandvei, R., Simonsen, E., Sorbe, B., Tholander, B. & 1 others, Westberg, R., 1998 Dec, In : Annals of oncology : official journal of the European Society for Medical Oncology. 9, 12, p. 1301-1307 7 p.

    Research output: Contribution to journalArticle

  33. 1993
  34. Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin

    Schmidt, M., Sorbe, B., T Högberg, Himmelmann, A., Räisänen, I., Stockmeyer, M. & de Bruijn, K. M., 1993, In : Annals of oncology : official journal of the European Society for Medical Oncology. 4 , Suppl 3, p. S31-S34

    Research output: Contribution to journalArticle

Previous 1 2 3 Next